Clinical Trials Browser

Phase EARLY_PHASE1 × EGFR Positive Non-small Cell Lung Cancer × toripalimab × Clear all

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Phase EARLY_PHASE1 Unknown

EGFR Positive Non-small Cell Lung Cancer